Literature DB >> 7111671

Treatment of diffuse proliferative lupus nephritis by intravenous high-dose methylprednisolone.

C Ponticelli, P Zucchelli, G Banfi, L Cagnoli, P Scalia, S Pasquali, E Imbasciati.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7111671

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


× No keyword cloud information.
  8 in total

1.  Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis.

Authors:  Oliver Lenz; Alessia Fornoni; Gabriel Contreras
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  New approaches to treating systemic lupus erythematosus.

Authors:  D Wofsy
Journal:  West J Med       Date:  1987-08

Review 3.  Current treatment recommendations for lupus nephritis.

Authors:  C Ponticelli
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

Review 4.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 5.  Treatment of lupus nephritis.

Authors:  Fayez F Hejaili; Louise M Moist; William F Clark
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  [Drug treatment of chronic glomerulonephritis: pro].

Authors:  K Kühn; J Brodehl; K M Koch; U Helmchen
Journal:  Klin Wochenschr       Date:  1985-09-16

7.  The coexistence of rheumatoid arthritis and systemic lupus erythematosus.

Authors:  C Venegoni; M Chevallard; G Mele; G Banfi; M Carrabba
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

8.  Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome.

Authors:  E Imbasciati; R Gusmano; A Edefonti; P Zucchelli; C Pozzi; C Grassi; M Della Volpe; F Perfumo; P Petrone; M Picca
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.